Work

A phase I trial of the combination of temsirolimus (TEM) and sorafenib (SOR) in advanced hepatocellular carcinoma (HCC).

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.tps213

Authors: R. K. Kelley, H. S. Nimeiri, M. T. Vergo, E. K. Bergsland, A. H. Ko, P. N. Munster, A. Reinert, M. F. Mulcahy, A. B. Benson, A. P. Venook

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W591006708

Cites:

Cited by: 7

Related to: 10